Nasdaq Prax News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq prax. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Prax Today - Breaking & Trending Today

Praxis Precision Medicines' (PRAX) "Buy" Rating Reaffirmed at HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Praxis Precision Medicines (NASDAQ:PRAX – Free Report) in a research note issued to investors on Friday morning, Benzinga reports. They currently have a $105.00 price objective on the stock. Other analysts have also issued reports about the company. Wedbush boosted their price objective on Praxis Precision […] ....

Acuta Capital Partners , Praxis Precision Medicines Inc , Citigroup Inc , Silverarc Capital Management , Jefferies Financial Group , Asset Management Inc , Praxis Precision Medicines , Free Report , Financial Group , Precision Medicines , Get Free Report , Capital Partners , Capital Management , Management Inc , Praxis Precision Medicines Daily , Nasdaq Prax , Reiterated Rating , Hc Wainwright ,

HC Wainwright Reiterates Buy Rating for Praxis Precision Medicines (NASDAQ:PRAX)

Praxis Precision Medicines (NASDAQ:PRAX – Get Free Report)‘s stock had its “buy” rating reissued by analysts at HC Wainwright in a research note issued to investors on Friday, Benzinga reports. They presently have a $105.00 target price on the stock. HC Wainwright’s target price would indicate a potential upside of 98.56% from the company’s previous […] ....

Praxis Precision Medicines Inc , Citigroup Inc , Jefferies Financial Group , Acuta Capital Partners , Connor Clark Lunn Investment Management Ltd , Praxis Precision Medicines , Get Free Report , Financial Group , Precision Medicines , Capital Partners , Lunn Investment Management , Praxis Precision Medicines Daily , Nasdaq Prax , Reiterated Rating , Hc Wainwright ,

Praxis Precision Medicines (NASDAQ:PRAX) Shares Gap Up to $50.74

Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Get Free Report) gapped up before the market opened on Friday . The stock had previously closed at $50.74, but opened at $52.12. Praxis Precision Medicines shares last traded at $51.46, with a volume of 28,341 shares trading hands. Analyst Upgrades and Downgrades Several research analysts recently […] ....

Jefferies Financial Group , Victory Capital Management Inc , York Mellon Corp , Praxis Precision Medicines Inc , Simplex Trading , Northern Trust Corp , Praxis Precision Medicines , Get Free Report , Precision Medicines , New York Mellon Corp , Capital Management , Trust Corp , Rhumbline Advisers , Praxis Precision Medicines Daily , Nasdaq Prax ,

Praxis Precision Medicines (NASDAQ:PRAX) Receives "Buy" Rating from HC Wainwright

Praxis Precision Medicines (NASDAQ:PRAX – Get Free Report)‘s stock had its “buy” rating restated by HC Wainwright in a research note issued to investors on Tuesday, Benzinga reports. They currently have a $105.00 price target on the stock. HC Wainwright’s price target would suggest a potential upside of 77.54% from the stock’s current price. A […] ....

Victory Capital Management Inc , Praxis Precision Medicines Inc , Wildcat Capital Management , Barclays Plc , Simplex Trading , Praxis Precision Medicines , Get Free Report , Precision Medicines , Praxis Precision , Capital Management , Praxis Precision Medicines Daily , Nasdaq Prax , Reiterated Rating , Hc Wainwright ,